Jason Yongsheng Chan

38PUBLICATIONS
120CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|Jul 11, 2026
Interpreting ctDNA dynamics in gastrointestinal stromal tumor (GIST) therapy-timing may be key.

|Jun 02, 2026
Mevalonate pathway rewiring driven by enhancer remodelling confers resistance to KRAS inhibitors in colorectal cancer.

|May 29, 2026
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

|Apr 01, 2026
Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers.

Jing Han Hong, Chern Han Yong, Hong Lee Heng

|Jan 16, 2026
Global access to commercial CAR T-cell therapies: a cross-sectional study of health technology assessment across the G20 countries.

Alex Y Ge, William B Feldman, Martin F Kaiser

|Oct 29, 2025
Advanced Classical Hodgkin Lymphoma Management in East and Southeast Asia: Real-World Challenges and Aspirations of the Asian Lymphoma Study Group.

Jason Yongsheng Chan, Ayumi Fujimoto, Gin Gin Gan

Pageof 7

Frequent Collaborators

9 joint publications

Choon Kiat Ong

8 joint publications

Jing Han Hong

8 joint publications

Bin Tean Teh

6 joint publications

Peiyong Guan